{"title":"(\u8ad6\u6587) VigiBase\u306eHPV\u30ef\u30af\u30c1\u30f3\u6709\u5bb3\u4e8b\u8c61\u5831\u544a\u306e\u7d71\u8a08\u89e3\u6790","version":"1.0","height":"190","type":"rich","blog_url":"https://usotsukibakari-3.hatenablog.com/","published":"2020-01-28 17:41:59","blog_title":"YuHi \u306e\u96d1\u611f","provider_url":"https://hatena.blog","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fusotsukibakari-3.hatenablog.com%2Fentry%2F3791d76a564c941f371a83e41e7f9d48\" title=\"(\u8ad6\u6587) VigiBase\u306eHPV\u30ef\u30af\u30c1\u30f3\u6709\u5bb3\u4e8b\u8c61\u5831\u544a\u306e\u7d71\u8a08\u89e3\u6790 - YuHi \u306e\u96d1\u611f\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","author_url":"https://blog.hatena.ne.jp/usotsukibakari_3/","provider_name":"Hatena Blog","categories":["\u8ad6\u6587"],"author_name":"usotsukibakari_3","image_url":"https://cdn-ak.f.st-hatena.com/images/fotolife/u/usotsukibakari_3/20250930/20250930204209.png","width":"100%","url":"https://usotsukibakari-3.hatenablog.com/entry/3791d76a564c941f371a83e41e7f9d48","description":"Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase(\u00ae). Drug Saf. 2017 Jan;40(1):81-90. doi:10.1007/s40264-016-0456-3.PubMed PMID: 27638661; PubMed Central PMCID: PMC5209415.\u4ee5\u524dTwitter\u3067\u7d39\u4ecb\u3057\u305f2017\u5e74\u306e\u8ad6\u6587\u3067\u3059\u3002\u5168\u6587\u30c0\u30a6\u30f3\u30ed\u30fc\u30c9\u3067\u304d\u307e\u3059\u3002Safety Concerns with Human Papillomavirus Vacci\u2026"}